Yongqing Liu Selected Research

Zinc Finger E-box-Binding Homeobox 1

1/2021	Zeb1 induces immune checkpoints to form an immunosuppressive envelope around invading cancer cells.
3/2015	An Rb1-dependent amplification loop between Ets1 and Zeb1 is evident in thymocyte differentiation and invasive lung adenocarcinoma.
12/2014	miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.
2/2014	The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression.
4/2013	Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongqing Liu Research Topics

Disease

26	Neoplasms (Cancer) 01/2021 - 02/2002
6	Neoplasm Metastasis (Metastasis) 11/2017 - 02/2008
4	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 11/2009
4	Hypoxia (Hypoxemia) 01/2022 - 04/2009
4	Influenza in Birds (Avian Flu) 09/2021 - 01/2018
3	Bacterial Infections (Bacterial Infection) 01/2021 - 12/2019
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2021 - 01/2019
3	Infections 11/2020 - 01/2019
3	Breast Neoplasms (Breast Cancer) 12/2014 - 07/2011
2	Macular Degeneration (Age-Related Maculopathy) 06/2021 - 04/2009
2	Peritonitis 11/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 02/2020 - 12/2019
2	Retinal Degeneration 01/2020 - 08/2017
1	Burns 04/2022
1	Blindness (Hysterical Blindness) 04/2022
1	Inflammation (Inflammations) 04/2022
1	ST Elevation Myocardial Infarction 04/2022
1	Chest Pain (Chest Pains) 04/2022
1	Heart Failure 04/2022
1	Heart Rupture 04/2022
1	Myocardial Infarction 04/2022
1	Hyperoxia 01/2021
1	Hemolysis 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Abscess 01/2020
1	Esophageal Squamous Cell Carcinoma 12/2019
1	Starvation 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Melanoma (Melanoma, Malignant) 11/2017
1	Azoospermia 09/2017
1	Epilepsy (Aura) 01/2017
1	Retinal Diseases 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Necrosis 01/2016
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2014

Drug/Important Bio-Agent (IBA)

9	Peptides (Polypeptides)IBA 09/2021 - 02/2002
7	VaccinesIBA 09/2021 - 08/2002
5	Zinc Finger E-box-Binding Homeobox 1IBA 01/2021 - 04/2013
3	bradykinin potentiating factorsIBA 09/2021 - 01/2018
3	Anti-Infective Agents (Microbicides)IBA 01/2021 - 01/2020
3	Retinaldehyde (Retinal)IBA 01/2020 - 08/2017
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020 - 12/2016
3	Transcription Factors (Transcription Factor)IBA 01/2018 - 02/2008
3	CD40 Ligand (CD40L)IBA 02/2005 - 02/2002
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 09/2021 - 11/2018
2	EpitopesIBA 09/2021 - 01/2021
2	Protein Subunit VaccinesIBA 09/2021 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 09/2021 - 06/2009
2	Therapeutic UsesIBA 11/2020 - 01/2020
2	Cisplatin (Platino)FDA LinkGeneric 12/2019 - 03/2018
2	Histones (Histone)IBA 01/2019 - 09/2017
2	retigeric acid BIBA 03/2018 - 08/2013
2	Cancer VaccinesIBA 06/2005 - 02/2002
2	1-palmitoyl-lysophosphatidic acid (PLPA)IBA 08/2003 - 02/2002
1	Docetaxel (Taxotere)FDA Link 10/2022
1	AlkaliesIBA 04/2022
1	pro-brain natriuretic peptide (1-76)IBA 04/2022
1	Long Noncoding RNAIBA 01/2022
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 09/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	Rhodopsin (Visual Purple)IBA 01/2021
1	porcine myeloid antibacterial peptide 23IBA 01/2021
1	AcidsIBA 02/2020
1	sodium aescinateIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	N- methyl- N- 2- (methylsulfinyl)ethylpropionic acid amide (NMPA)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	PolymersIBA 01/2020
1	flavokawain AIBA 01/2020
1	icaritinIBA 12/2019
1	PMAP-37IBA 12/2019
1	Acid Rain (Acid Rains)IBA 11/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	AntigensIBA 01/2018
1	Voltage-Gated Sodium ChannelsIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 01/2016
1	CaspasesIBA 01/2016
1	Radiation-Sensitizing AgentsIBA 12/2014
1	MicroRNAs (MicroRNA)IBA 12/2014
1	VitronectinIBA 12/2014
1	LigandsIBA 12/2014
1	Phosphotransferases (Kinase)IBA 09/2014
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2014
1	Topoisomerase II InhibitorsIBA 08/2013
1	trioctyl phosphine oxide (TOPO)IBA 08/2013

Therapy/Procedure

10	Therapeutics 06/2021 - 02/2002
3	Immunotherapy 01/2021 - 08/2002
1	Percutaneous Coronary Intervention 04/2022
1	Transplantation 01/2020
1	Transjugular Intrahepatic Portasystemic Shunt 01/2019
1	Telescopes 11/2017
1	Intravitreal Injections 11/2017